Invasive Fungal Breakthrough Infections under Targeted Echinocandin Prophylaxis in High-Risk Liver Transplant Recipients

Invasive Fungal Breakthrough Infections under Targeted Echinocandin Prophylaxis in High-Risk Liver Transplant Recipients

Invasive fungal infections (IFIs) are frequent and outcome-relevant complications in the early postoperative period after orthotopic liver transplantation (OLT). Recent guidelines recommend targeted antimycotic prophylaxis (TAP) for high-risk liver transplant recipients (HR-LTRs). However, the choic...

Full description

Bibliographic Details
Main Authors:	Robert Breitkopf, Benedikt Treml, Thomas Senoner, Zoran Bukumirić, Sasa Rajsic
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	Journal of Fungi
Subjects:	liver transplantation targeted antimycotic prophylaxis echinocandins invasive fungal infections breakthrough infections
Online Access:	https://www.mdpi.com/2309-608X/9/2/272

Similar Items

Review on Current Status of Echinocandins Use
by: Martyna Mroczyńska, et al.
Published: (2020-05-01)

The current place of echinocandins in the treatment and prophylaxis of invasive fungal infections
by: Veselov A.V.
Published: (2020-10-01)

Breakthrough Invasive Fungal Infections in Allogeneic Hematopoietic Stem Cell Transplantation
by: Carmine Liberatore, et al.
Published: (2021-04-01)

Invasive Fungal Infections: The Early Killer after Liver Transplantation
by: Robert Breitkopf, et al.
Published: (2023-06-01)

Antifungal effects of echinocandins diminish when exposed to intestinal lumen contents: a finding with potentially significant clinical implications
by: Sepideh Mehravar, et al.
Published: (2024-03-01)

Fungal infections in marrow transplant recipients under antifungal prophylaxis with fluconazole
by: Oliveira J.S.R., et al.
Published: (2002-01-01)

Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China
by: Yating Ning, et al.
Published: (2023-12-01)

Predictors of breakthrough clinically significant cytomegalovirus infection during letermovir prophylaxis in high‐risk hematopoietic cell transplant recipients
by: Léna Royston, et al.
Published: (2021-09-01)

In Vitro Activitiy of Rezafungin in Comparison with Anidulafungin and Caspofungin against Invasive Fungal Isolates (2017 to 2022) in China
by: Simin Yang, et al.
Published: (2024-05-01)

Diagnosis of Breakthrough Fungal Infections in the Clinical Mycology Laboratory: An ECMM Consensus Statement
by: Jeffrey D. Jenks, et al.
Published: (2020-10-01)

Review of the Novel Echinocandin Antifungal Rezafungin: Animal Studies and Clinical Data
by: Yanan Zhao, et al.
Published: (2020-09-01)

Universal antifungal prophylaxis effectively prevents fungal bloodstream infection in pediatric liver transplant recipients: a retrospective real-world study
by: Weili Wang, et al.
Published: (2024-06-01)

Fungal Infections and Myeloma: Supports
by: İrfan Yavaşoğlu
Published: (2023-08-01)

Echinocandins as Biotechnological Tools for Treating <i>Candida auris</i> Infections
by: Elizabete de Souza Cândido, et al.
Published: (2020-09-01)

Antifungal Prophylaxis in Solid Organ Transplant Recipients
by: Şebnem ŞENOL, et al.
Published: (2015-12-01)

Cerebral and pulmonary aspergillosis, treatment and diagnostic challenges of mixed breakthrough invasive fungal infections: case report study
by: Ali Amanati, et al.
Published: (2020-07-01)

Post-Prescription Audit Plus Beta-D-Glucan Assessment Decrease Echinocandin Use in People with Suspected Invasive Candidiasis
by: Rita Murri, et al.
Published: (2021-06-01)

Comparative study of prophylaxis with high and low doses of voriconazole in children with malignancy
by: Sviatlana Kandaurava, et al.
Published: (2020-12-01)

Recurrent episodes of Candidemia due to Candida glabrata, Candida tropicalis and Candida albicans with acquired echinocandin resistance
by: Marine Grosset, et al.
Published: (2016-12-01)

Epidemiology and Prognosis of Invasive Fungal Disease in Chinese Lung Transplant Recipients
by: Chunrong Ju, et al.
Published: (2021-10-01)

Adverse Events Associated with Universal versus Targeted Antifungal Prophylaxis among Lung Transplant Recipients—A Nationwide Cohort Study 2010–2019
by: Cornelia Geisler Crone, et al.
Published: (2022-12-01)

Perspectives on the Use of Echinocandins in the Neonatal Intensive Care Unit
by: Niki Dermitzaki, et al.
Published: (2024-12-01)

Recommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4)
by: Can Boğa, et al.
Published: (2015-05-01)

FDA-Approved Antibacterials and Echinocandins
by: Othman Al Musaimi
Published: (2025-02-01)

Fungal Resistance to Echinocandins and the MDR Phenomenon in Candida glabrata
by: Kelley R. Healey, et al.
Published: (2018-09-01)

Recent Insights into the Paradoxical Effect of Echinocandins
by: Johannes Wagener, et al.
Published: (2017-12-01)

Periprosthetic Fungal Infections in Severe Endoprosthetic Infections of the Hip and Knee Joint—A Retrospective Analysis of a Certified Arthroplasty Centre of Excellence
by: Andreas Enz, et al.
Published: (2021-05-01)

Some issues of the resistance of Candida glabrata to echinocandins
by: Veselov A.V.
Published: (2019-12-01)

The in vitro Activity of Echinocandins Against Clinical Trichophyton rubrum Isolates and Review of the Susceptibility of T. rubrum to Echinocandins Worldwide
by: Su H, et al.
Published: (2023-08-01)

Clinical characteristics and risk factors of invasive fungal disease after hematopoietic stem cell transplantation: report of 233 cases
by: MA Lei, et al.
Published: (2020-09-01)

Refractory fungal infection: Three case reports highlighting good practice
by: Rosemary Barnes, et al.
Published: (2024-12-01)

Impact of fluconazole versus posaconazole prophylaxis on the incidence of fungal infections in patients receiving induction chemotherapy for acute myeloid leukemia
by: Camille Devanlay, et al.
Published: (2015-06-01)

Invasive Fungal Disease in Patients with Newly Diagnosed Acute Myeloid Leukemia
by: Anastasia I. Wasylyshyn, et al.
Published: (2021-09-01)

Guideline for diagnosis, prophylaxis and treatment of invasive fungal infection post burn injury in China 2013
by: Gaoxing Luo, et al.
Published: (2014-04-01)

Invasive Fungal Infection in Hematopoietic Stem Cell Transplant Recipient from an Indian Oncology Setting
by: Abdul Ghafur, et al.
Published: (2024-07-01)

Clinical and microbiological analysis of risk factors for breakthrough bloodstream infection during Tigecycline Therapy
by: Sol Jin, et al.
Published: (2025-02-01)

Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol)
by: Michele Malagola, et al.
Published: (2022-06-01)

Predictors of breakthrough invasive fungal infections (BIFI) in pediatric acute leukemia: a retrospective analysis and predictive model development
by: Yan Li, et al.
Published: (2024-12-01)

First case of fungemia caused by a rare and pan-echinocandin resistant yeast Sporopachydermia lactativora in China
by: Qiushi Zheng, et al.
Published: (2024-10-01)

Fatal Breakthrough Candidemia in an Immunocompromised Patient in Kuwait Due to <i>Candida auris</i> Exhibiting Reduced Susceptibility to Echinocandins and Carrying a Novel Mutation in Hotspot-1 of <i>FKS1</i>
by: Inaam Al-Obaid, et al.
Published: (2022-03-01)